Integra LifeSciences | IART - 股票



金融业
股票价格
USD
资产
USD 3.6B
现金及等价物
USD 235.05M
销售成本
USD 193.45M
流动资产
USD 1.16B
流动负债
USD 455.98M
债务
USD 2.01B
EBIT
USD 66.01M
EBITDA
USD 104.21M
员工
4.4K
EPS每股收益
USD 0.83
股本和储备
USD 1.04B
销售毛利
USD 217.1M
债务利息支出
USD 23.67M
利息收入
USD 4.98M
贷款资金
USD 1.86B
市值
USD 746.2M
净收入
USD -1.7M
营业费用
USD 368.92M
营业利润
USD 66.01M
普通股股本
USD 77.89M
PE价格收益
6.59
税前利润
USD -6.82M
销售收入
USD 434.9M
销售和管理费用
USD 156.45M
股票
USD 492.74M
贸易债权人
USD 95.73M
应收帐款人
USD 278.85M


股票 更改 日
Abbott USD 6.49B 220M 2025-12
AtriCure USD 78.49M 459K 2025-12
Baxter International USD 2.23B 228M 2025-12
Becton, Dickinson and Co. USD 4.08B 191M 2025-12
Boston Scientific USD 2.94B 22M 2025-12
CONMED USD 355.54M 8.81M 2025-12
Cooper Companies USD 846M 35M 2025-09
Dexcom USD 629.1M 25M 2025-12
Edwards Lifesciences USD 1.14B 800K 2025-09
Globus Medical USD 759.28M 12.26M 2025-12
Hologic USD 688.5M 9.1M 2025-12
Insulet USD 452.6M 6.3M 2025-12
Integra LifeSciences USD 492.73M 3.63M 2025-12
Intuitive Surgical USD 1.84B 58.1M 2025-12
J&J USD 14.19B 45M 2025-12
Medtronic USD 6.31B 153M 2025-12
Merit Medical Systems USD 333.7M 7.15M 2025-12
Orthofix International USD 172.32M 1.72M 2025-12
Stryker USD 5.31B 60M 2025-12
Tandem Diabetes Care USD 128.77M 8.51M 2025-12
Teleflex USD 802.46M 108.78M 2025-09
Zimmer Biomet Holdings USD 2.29B 197.3M 2025-12